Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Heterotopic bone formation in the gastrointestinal tract.

Haque S, Eisen RN, West AB.

Arch Pathol Lab Med. 1996 Jul;120(7):666-70. Review.

PMID:
8757473
2.

Heterotopic bone formation in two cases of colon carcinoma.

Alper M, Akyürek N, Patiroğlu TE, Yüksel O, Belenli O.

Scand J Gastroenterol. 2000 May;35(5):556-8.

PMID:
10868462
3.

Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.

Am J Gastroenterol. 2005 Jun;100(6):1257-64.

PMID:
15929754
4.

Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.

Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ.

J Surg Res. 2006 Oct;135(2):337-44. Epub 2006 Aug 22.

PMID:
16926029
5.

Heterotopic bone formation in rectal carcinoma. Case report and literature review.

Ansari MQ, Sachs IL, Max E, Alpert LC.

Dig Dis Sci. 1992 Oct;37(10):1624-9. Review.

PMID:
1396010
6.

Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.

Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.

Histopathology. 1999 Dec;35(6):517-24.

PMID:
10583575
8.

[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].

Endzinas Z, Mickevicius A, Kiudelis M.

Zentralbl Chir. 2004 Apr;129(2):99-103. German.

PMID:
15106039
9.
10.

Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.

Fisher RS, Bromer MQ, Thomas RM, Cohen S, Krevsky B, Horwitz B, Glazier KD, Das K, Das KM.

Am J Gastroenterol. 2003 Sep;98(9):1945-51.

PMID:
14499770
11.

Mucin histochemistry of esophagus in health and malignancy.

Shet T, Desai S, Prabhu S, Amarapurkar D.

Indian J Gastroenterol. 1997 Oct;16(4):140-1.

PMID:
9357185
12.

Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.

Fortun PJ, Anagnostopoulos GK, Kaye P, James M, Foley S, Samuel S, Shonde A, Badreldin R, Campbell E, Hawkey CJ, Ragunath K.

Aliment Pharmacol Ther. 2006 Mar 15;23(6):735-42.

13.

[Specialized intestinal metaplasia of the distal esophagus in gastroesophageal reflux disease: prevalence and clinico-demographic features].

Caum LC, Bizinelli SL, Pisani JC, Amarantes HM, Ioshii SO, Carmes ER.

Arq Gastroenterol. 2003 Oct-Dec;40(4):220-6. Epub 2004 May 31. Portuguese.

14.

Heterotopic gastric mucosa of the gastrointestinal tract: a histopathologic study of 158 cases.

Terada T.

Pathol Res Pract. 2011 Mar 15;207(3):148-50. doi: 10.1016/j.prp.2010.12.004. Epub 2011 Jan 16.

PMID:
21242038
15.

Case report of heterotopic bone formation in metastatic carcinoma of the colon.

Caluori D, Gallo P.

Tumori. 1979 Jun 30;65(3):345-51.

PMID:
111384
16.
17.

Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.

Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD.

Hum Pathol. 2001 Nov;32(11):1157-65.

PMID:
11727253
18.

Barrett's esophagus: best of Digestive Disease Week 2003.

Jean M, Dua K.

Curr Gastroenterol Rep. 2004 Jun;6(3):202-5. Review.

PMID:
15128485
19.

Origin of adenocarcinoma in Barrett's esophagus: p53 and Ki67 expression and histopathologic background.

Szachnowicz S, Cecconello I, Iriya K, Marson AG, Takeda FR, Gama-Rodrigues JJ.

Clinics (Sao Paulo). 2005 Apr;60(2):103-12. Epub 2005 Apr 26.

20.

Supplemental Content

Support Center